Sanofi (NYSE: SNY) will pay a premium of approximately $11.6 billion in cash to acquire Bioverativ Inc. (Nasdaq: BIVV). Shares of Sanofi dropped $1.40 to close at $43.20 while Bioverativ stop leaped $39.68 to close at $103.79.
Sanofi to buy Bioverativ
January 22, 2018 at 16:12 PM EST